Stay on top of the latest long-term care news with our monthly Quality Digest newsletter.
View in browser
PMC QD headers 2024 june
PMC clinical news 2024 orange-1

Did You Know? Insulin Comparison Chart

Our comprehensive chart summarizes available insulin preparations, including duration of action, when to inject, storage specifications, and more.

LEARN MORE >

E-guide: Drug Diversion A-to-Z

Temptation and opportunity make drug diversion a significant risk in long-term care. In our e-guide, learn more about commonly diverted drugs, how to recognize the signs that diversion might be occurring, and steps you can take to prevent it.

LEARN MORE >

E-guide: Polypharmacy in Senior Living

Polypharmacy can be dangerous for anyone, but seniors are especially vulnerable. In this new e-guide, learn about the causes of polypharmacy, how to recognize the signs, and the role of deprescribing to improve residents' health and quality of life. 

LEARN MORE >

Alzheimer's and Brain Awareness Month

June is Alzheimer's and Brain Awareness Month. The Alzheimer’s Association is a nonprofit health organization that promotes advances in care, support, and research on Alzheimer’s Disease. The association maintains numerous resources to support those providing care to people with Alzheimer’s and other forms of dementia. Check out these free and on-demand resources in their online Education Center.

LEARN MORE >

Agitation Associated with Dementia Due to Alzheimer's Disease: A Novel Indication

2023 saw the first FDA approval for the indication "agitation associated with dementia due to Alzheimer’s disease" (AAD) awarded to Rexulti (brexpiprazole). Rexulti's manufacturer, Otsuka Pharmaceuticals, supports a psychiatric clinical information platform – PsychU® – which houses helpful resources for healthcare providers, caregivers, and patients. One such resource is the Agitation in Alzheimer’s Screener for Caregivers, a survey designed to assist in recognizing potentially unaddressed AAD. 

LEARN MORE >
PMC reg updates 2024 blue-1

Compliance Cue F758: Free from Unnecessary Psychotropic Medications/PRN Use 

Dedicated solely to psychotropic medications, F758 underscores the heightened level of scrutiny applied to this drug class. Areas of focus include expansion of the definition of psychotropics, increasing surveillance, and guidance on gradual dose reductions (GDRs). Learn more about the requirements associated with F758, what surveyors will look for, and how your facility can stay in compliance.

LEARN MORE >
PMC upcoming events 2024 grey-2
PharMerica Illuminate header
psychotropic webinar July 2024-1

WEBINAR:

Pragmatic Approaches to Psychotropic Medication Stewardship

Tuesday, July 16

1pm ET

REGISTER >
PharMerica McKnight's podcast at NADONA June 2024

Headed to the NADONA Conference?

Join us for our LIVE PODCAST! 

Ever wonder why some nursing homes shine brighter than the rest? One key is the remarkable success stories of their Directors of Nursing (DONs) and nurse leaders. Join us at the NADONA conference on June 25 for an exclusive live podcast in which we delve into the intriguing topic of how Success Breeds Success. 

PharM logo no tag - WHITE-3
Facebook
LinkedIn
X

PharMerica, 805 N. Whittington Pkwy, Louisville, KY 40222, United States

Unsubscribe Manage preferences